Related Experiment Video
Updated: Apr 5, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Probabilistic issues with sentinel lymph nodes in malignant melanoma
1From the VA and Duke University Medical Centers, Durham, NC. Robin.Vollmer@med.va.gov.
Probability analysis of sentinel lymph node biopsy in melanoma reveals that while results correlate with tumor thickness and node count, they do not identify all patients with metastatic melanoma.
Area of Science:
- Oncology
- Biostatistics
Background:
- Sentinel lymph node biopsy is a critical staging procedure for melanoma.
- Understanding the probabilistic nature of sentinel lymph node (SLN) results is essential for accurate patient management.
Purpose of the Study:
- To analyze the probability of sentinel lymph node (SLN) metastasis in melanoma.
- To investigate the relationship between SLN results, tumor thickness, and patient outcomes.
Main Methods:
- Utilized discrete exponential probability distribution to model the number of positive SLNs.
- Applied mathematical functions derived from survival analysis to assess probability relationships.
- Extracted and analyzed data from existing literature.
Main Results:
- The number of positive and negative SLNs observed aligns with discrete exponential probability distributions.
- The probability of a positive SLN is closely related to tumor thickness via a survival analysis-derived function.
- SLN results correlate with tumor thickness and total nodes harvested but have limitations in predicting all future metastases.
Conclusions:
- Probability analysis offers valuable insights into the efficacy and limitations of SLN biopsy in melanoma patients.
- This approach enhances understanding of SLN biopsy performance in melanoma staging.
More Related Videos
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021